Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Network Comparison Type Value Type Interaction Map Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 51 to 100 of 3730 in total 
Network Comparison Type: Divided
Value Type: Ranked
Interaction Map: High confidence

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Filtered\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
26\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dystrobrevin binding protein 1; dysbindin. [source:refseq;acc:nm\_032122]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7533.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12128.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.60995\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 3 (ec 2.7.1.33) (pantothenic acid kinase 3) (hpank3). [source:swissprot;acc:q9h999]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
44\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
58\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.31818\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
27\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ptd016 protein. [source:refseq;acc:nm\_016125]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11234\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18050\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.60673\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
28\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-3 (activating transcription factor 3). [source:swissprot;acc:p18847]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
153.671\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.949\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31416\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
p28 ing5. [source:refseq;acc:nm\_032329]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7562.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12124.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.60337\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
29\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
phenylethanolamine n-methyltransferase (ec 2.1.1.28) (pnmtase) (noradrenaline n-methyltransferase). [source:swissprot;acc:p11086]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
11625\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7395\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.57201\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
uncharacterized hematopoietic stem/progenitor cells protein mds026. [source:sptrembl;acc:q9nz48]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.678\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
187.458\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.29991\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
30\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-carotene dioxygenase 2; putative b,b-carotene-9',10'-dioxygenase. [source:refseq;acc:nm\_031938]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11625\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7395\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.57201\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, alpha isoform (pp2a, subunit b, b-alpha isoform) (pp2a, subunit b, b55-alpha isoform) (pp2a, subunit b, pr55-alpha isoform) (pp2a, subunit b, r2-alpha isoform). [source:swissprot;acc:q00007]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.678\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
187.457\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.29991\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
31\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
leucine rich repeat (in flii) interacting protein 1. [source:refseq;acc:nm\_004735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5266.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8082.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.53462\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, beta isoform (pp2a, subunit b, b-beta isoform) (pp2a, subunit b, b55- beta isoform) (pp2a, subunit b, pr55-beta isoform) (pp2a, subunit b, r2-beta isoform). [source:swissprot;acc:q00005]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.677\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
187.458\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2999\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
32\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin 9. [source:refseq;acc:nm\_018085]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8691.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13292.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.52929\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, gamma isoform (pp2a, subunit b, b-gamma isoform) (pp2a, subunit b, b55-gamma isoform) (pp2a, subunit b, pr55-gamma isoform) (pp2a, subunit b, r2-gamma isoform) (imypno1). [source:swissprot;acc:q9y2t4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.673\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
187.462\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.29985\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
33\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleosome assembly protein 1-like 4 (nucleosome assembly protein 2) (nap2). [source:swissprot;acc:q99733]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8691.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13292.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.52929\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, beta isoform (pp2a, subunit a, pr65-beta isoform) (pp2a, subunit a, r1-beta isoform). [source:swissprot;acc:p30154]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
242.742\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
188.688\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.28647\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
34\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated protein, rp/eb family, member 2; t-cell activation protein, eb1 family; apc-binding protein eb1. [source:refseq;acc:nm\_014268]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17173.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11284\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.52196\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, alpha isoform (pp2a, subunit a, pr65-alpha isoform) (pp2a, subunit a, r1-alpha isoform) (medium tumor antigen-associated 61 kda protein). [source:swissprot;acc:p30153]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
242.453\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
189.07\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.28235\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
35\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear dna-binding protein; small unique nuclear receptor corepressor; c1d dna-binding protein. [source:refseq;acc:nm\_006333]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4871.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3208.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.5182\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear transcription factor y subunit gamma (nf-y protein chain c) (nuclear factor yc) (nf-yc) (ccaat-binding transcription factor subunit c) (cbf-c) (transactivator hsm-1/2). [source:swissprot;acc:q13952]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
204.309\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
260.532\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.27519\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
36\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat-binding transcription factor subunit b (cbf-b) (nf-y protein chain a) (nf-ya) (caat-box dna binding protein subunit a). [source:swissprot;acc:p23511]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit-like protein 1 (g protein beta-subunit like protein 1) (wd40 repeat containing protein deleted in vcfs) (wdvcf protein) (fksg1 protein) (dgcrk3). [source:swissprot;acc:q9byb4]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
14964\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
22422\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.4984\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
37\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj570f3.6 (novel protein similar to lysophospholipase ii (lypla2)). [source:sptrembl;acc:q9uge0]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
2582\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3859\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.49458\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14a; 17-kda pkc-potentiated inhibitory protein of pp1. [source:refseq;acc:nm\_033256]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
253\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
322\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.27273\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
38\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 8 (ec 2.7.1.-) (protein kinase k35). [source:swissprot;acc:p49336]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10771\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7230\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.48976\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
microfibril-associated glycoprotein 4 precursor. [source:swissprot;acc:p55083]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
253\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
322\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.27273\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
39\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ero1-like. [source:refseq;acc:nm\_014584]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20536\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13853\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.48242\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 14d; pkc-dependent pp1 inhibitory protein. [source:refseq;acc:nm\_017726]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
253\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
322\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.27273\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
40\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ficolin 2 precursor (collagen/fibrinogen domain-containing protein 2) (ficolin-b) (ficolin b) (serum lectin p35) (ebp-37) (hucolin) (l- ficolin). [source:swissprot;acc:q15485]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
filamin a (alpha-filamin) (filamin 1) (endothelial actin-binding protein) (abp-280) (nonmuscle filamin). [source:swissprot;acc:p21333]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5699\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3845\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.48218\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
41\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l21. [source:swissprot;acc:p46778]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6758.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9994.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.47871\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
253\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
322\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.27273\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
42\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, liver isoform t2 (adp/atp translocase 3) (adenine nucleotide translocator 3) (ant 3). [source:swissprot;acc:p12236]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5530.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8158\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.47509\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene protein c-fos (cellular oncogene fos) (g0/g1 switch regulatory protein 7). [source:swissprot;acc:p01100]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
160.957\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.641\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2714\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
43\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutathione s-transferase theta 2 (ec 2.5.1.18) (gst class-theta). [source:swissprot;acc:p30712]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8356.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12143.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.4533\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
jun dimerization protein. [source:refseq;acc:nm\_130469]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
160.957\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
204.641\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2714\vspace{3pt}}\\\cline{1-2}\cline{4-4}\cline{6-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
44\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
161.046\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
1.2707\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serpin b12. [source:swissprot;acc:q96p63]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
21138.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14604.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.44743\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
45\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hurpin (hacat uv-repressible serpin) (protease inhibitor 13) (headpin) (serpin b13). [source:swissprot;acc:q9uiv8]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
21113.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14592\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.44694\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein fosb (g0/g1 switch regulatory protein 3). [source:swissprot;acc:p53539]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
161.051\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.641\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.27066\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
46\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l37a. [source:swissprot;acc:p12751]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
18499.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12941.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.42943\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 1 (fra-1). [source:swissprot;acc:p15407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
161.068\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.642\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.27053\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
47\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial precursor (ec 1.14.-.-) (25-ohd-1 alpha-hydroxylase) (25-hydroxyvitamin d3 1- alpha-hydroxylase) (vd3 1a hydroxylase) (p450c1 alpha) (p450vd1- alpha). [source:swissprot;acc:o15528]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
18499.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12941.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.42943\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
256.492\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
325.586\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26938\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
48\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gaba(a) receptor-associated protein; gaba(a)-receptor-associated protein. [source:refseq;acc:nm\_007278]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
83.0461\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
65.4586\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26868\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 13 kda-b subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-13kd-b) (ci-13kd-b) (complex i subunit b13). [source:swissprot;acc:q16718]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6909\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9830\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.42278\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
49\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 2 (arrestin, beta 2). [source:swissprot;acc:p32121]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
105\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
133\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26667\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
brain protein 16. [source:refseq;acc:nm\_016458]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4854.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6890.54\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.41927\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
50\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 1 (arrestin, beta 1). [source:swissprot;acc:p49407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
105\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
133\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26667\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cartilage oligomeric matrix protein precursor (comp). [source:swissprot;acc:p49747]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13091.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9249.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.41533\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/